Ring 1
Ring 2
Ring 3
Ring 4

Ensoma

Financing Round

  • Series A
Round Led by Symbiosis

Ensoma believes the future of medicine lies within us. Its Engenious™ gene therapy platform is the first to precisely engineer any or all hematopoietic and immune cells with a one-time, off-the-shelf in vivo treatment. Engenious therapies have an unmatched capacity to deliver all modern genetic modification tools and set a new standard for versatile cell programming and control across a range of complex diseases.

ensoma View Website

Modality

  • Genetic Medicine

Indication

  • Other

Development Status

  • Pre-Clinical

Learn More About Ensoma

Name(Required)